Tag Archives: national

Pakistan – Local lawmakers will be consulted for development projects in the merged districts | Instant News

(MENAFN – Tribal News Network) PESHAWAR: Chief Minister Khyber Pakhtunkhwa Mehmood Khan chaired a consultative meeting of Members of the National Assembly and KP Councils from joint tribal districts in Peshawar on Saturday where annual development programs for tribal districts were discussed.

All MPs from the joint district including the Federal Minister for Religious Affairs Noorul Haq Qadri attended the meeting.

The chief minister said while speaking at the meeting that the rapid development of tribal districts was one of the government’s top priorities. He said the government under the leadership of Prime Minister Imran Khan took concrete steps to develop the tribal district.

Mehmood Khan said he personally monitored development projects in the merged areas. He said no compromise would be made on completing the construction project on time. He assured that all development projects in the combined area would begin after consultation with local MPs.

The chief minister said the government under the vision of Prime Minister Imran Khan completed the merger of Fata with Khyber Pakhtunkhwa in an appropriate manner. He said the merger benefits had already begun and more benefits would soon emerge.

Mehmood Khan said that although the government faces the problem of limited resources, it will not dampen the government’s determination to develop the merged regions. He said the consultation process with members of parliament from the merged regions would continue in the future. He said development projects identified by elected representatives would be included in the annual development program.

IGFC provides Rs100,000 for the care of sick girls

Inspector General Frontier Corps (IGFC) South has provided Rs100,000 for the care of a 15-year-old sick girl in South Waziristan.

Local sources said the daughter of Sherpao Mehsud, a resident of Civil Lines Tank, had a tumor on his head and the poor man was unable to pay for his treatment. He had appealed to IGFC Grand General Azhar Abbasi, Deputy Commissioner of Tanks, Southern Sector Commander and wealthy people to help him with the treatment of his ailing doctor.

IGFC South after learning about this problem, IGFC South provided Rs 100,000 for the care of the girl.



image source

The Halifax laboratory team will conduct the first Canadian trial for a possible COVID-19 vaccine | Instant News

HALIFAX – Canada’s first clinical trial for a possible COVID-19 vaccine will be carried out by a Halifax research team who was also involved in a trial that eventually led to a vaccine for the Ebola virus.

Health Canada has approved a trial to be carried out at the Canadian Vaccine Center at Dalhousie University.

The director of the center, Dr. Scott Halperin, said the lab was one of several in Canada and the US whose work began in 2014 finally saw an “emergency release” of the Ebola vaccine used in West Africa before the third phase of clinical trials had been completed.

Halperin said each lab conducted a slightly different study to get the right type of information before quickly moving to the second and then third phases.

“Phase 1 studies were carried out and within six months data were available and a phase three study was started in West Africa which then helped to completely stop the epidemic,” he said in an interview.

Halperin said the possibility of a similar emergency release could occur in Canada with a potential COVID-19 vaccine if it showed potential and was considered safe, speeding up a process that usually takes several years to complete – anywhere from five to seven years under normal circumstances.

“That would be something that Health Canada and the Canadian government must decide if they want to do that. But that is certainly one of the choices in the tool kit of things they can do to speed up the process if this or other vaccines seem promising.”

Halperin pointed out that although used earlier during testing, the Ebola vaccine was not actually licensed as a vaccine that was marketed regularly until late last year.

However, he warned there was a lot of work to be done before the COVID-19 vaccine could be approved for use.

Halifax researchers will follow up on the work by Chinese manufacturer CanSino Biologics, which has conducted human clinical trials for vaccines.

Halperin said the first phase of the trial would take place in the next three weeks after final approval was given by the central research ethics council.

Phase 1 will involve less than 100 healthy volunteers between the ages of 18 and 55 who will be followed for the next six months.

“We want to make sure that the vaccine is safe in younger individuals before we go to people who might be at higher risk,” Halperin said.

Participants were given vaccine doses and clinically monitored through a series of blood tests. They were also asked to record their symptoms in a diary so the researchers could have more information.

“We collected all kinds of symptoms that they might have whether they thought it was related to the vaccine or not,” Halperin said.

Each participant will make between nine and 13 visits to the center during the first phase of the study.

If the initial test group shows a safe immune response to the vaccine, Halperin said the researchers will quickly move to an expanded second-phase study before even the first phase is finished.

It will involve hundreds of people of all ages, including those aged 65 to 85 years, and will be managed by several other research centers across the country that are part of the Canadian Immunization Research Network.

Halperin said the network was established by the federal government in 2009 as part of the response to the H1N1 pandemic. He said the aim was to create the infrastructure needed to respond quickly to emergencies and to conduct early phase clinical trials so that vaccines would be available in Canada.

“This is a good test for it (tissue),” Halperin said of clinical trials that will be the first of “many more to come.”

The Canadian Press report was first published on May 17, 2020.


image source

The latest developments on COVID-19 in Canada | Instant News

Latest news about the global pandemic COVID-19 (throughout the East):

1:40 p.m.

Nova Scotia reported three new cases of COVID-19, bringing the total number of provincial confirmed cases to 1,040.

The province reported no new deaths from the virus for two consecutive days after four deaths reported Friday made a total of 55.

There are two licensed long-term care homes and unlicensed senior facilities in Nova Scotia with active cases of COVID-19.

Northwood, in Halifax, currently has 24 residents and nine active case staff, while other facilities have one resident with COVID-19 active.

Eight people are currently in hospital, with four in intensive care, while 938 people have now recovered and their COVID-19 cases are considered resolved.

1:20 p.m.

The Quebec government reported 79 new deaths due to COVID-19, bringing the total to the province at 3,562.

There were also 737 new cases, bringing the total to 42,920.

Hospitalization increased slightly, as did the number of people in intensive care.

The province said 11,754 people had recovered from the disease.

12:50 a.m.

Newfoundland and Labrador reported no new confirmed COVID-19 cases.

This is the 10th day in a row without a case, bringing the total number of confirmed provinces to 260.

Health officials said three people were in the hospital because of the virus, with one in intensive care.

There have been three deaths due to COVID-19, while 249 people have recovered from the virus.

11:25 in the morning

Public health officials in New Brunswick report no new cases of COVID-19.

The number of confirmed cases in the province remains 120.

Officials said there were no active cases and all patients known to have contracted the virus had recovered.

To date, 20,317 tests have been carried out.

11 AM

COVID-19 statistics in Canada reached today’s milestone.

Following the daily reporting of Ontario figures, more than 50 percent of the country’s total cases were marked as completed.

With the rest of the provinces and territories to be reported on Sunday, 50.1 percent of the 76,193 Canadian cases are now considered to have been resolved.

10:45 a.m.

Ontario reported 340 new cases of COVID-19 and 23 new deaths.

There are now a total of 22,653 confirmed cases, including 1,881 deaths and 17,360 completed cases.

The growth rate compared to yesterday’s total was 1.5 percent, which is lower than yesterday’s level.

Copyright © Peak of the Powell River


image source

Swiss – National Bank snubs calls for more coronavirus money | Instant News

(MENAFN – Swissinfo) National Bank snubs calls for more coronavirus money

May 16, 2020 – 2:29 p.m.

Swiss National Bank (SNB) has rejected demands to increase its payments to help the economy cope with the cost of a coronavirus pandemic.

Member of the governing board Andréa Maechler additional financial contributions will ward off monetary policy.

“We have made our contribution to efforts to overcome the crisis not only by intervening in the currency market,” he told the Neue Zürcher Zeitung newspaper in a broad interview.

He said Switzerland experienced a stronger shock than previously thought but the SNB’s role did not change – to ensure monetary conditions through interest rates and foreign exchange rates.

Maechler said the CHF4 billion ($ 4.1 billion) payment to the Swiss government and 26 cantons this year was the maximum that the central bank could estimate. The bank made a surplus of around CHF49 billion in 2019.

+ The Minister of Finance sees a central bank surplus to reduce expected debt

A quick recovery from the Swiss economy is impossible, he said.

“The rules of social alienation, higher debt and higher unemployment and lower salaries will mean that more time is needed for the economy to recover,” he said.

Maechler, one of three central bank directorate members, said the SNB was not afraid of inflation or a deflationary spiral in Switzerland despite pressure from a strong Swiss franc and oil price shocks.



image source

Link to the First Large Scale Study of Acute Kidney Injury and Inpatient COVID-19 | Business | Instant News

MANHASSET, N.Y .– (WIRE BUSINESS) – May 14, 2020–

Doctors and researchers from various directions Northwell Health New York-based hospitals see “alarming numbers” of coronavirus disease hospitalized in 2019 (COVID-19) patients suffering from acute kidney injury (AKI) during the peak of the pandemic – levels higher than those reported from China, according to new data published in International Kidney, official journal of the International Society of Nephrology (ISN).

Drs. Kenar Jhaveri and Steven Fishbane did a round at the North Shore University Hospital on COVID-19 patients with acute kidney injury. (Credit: Feinstein Medical Research Institute)

In the largest study of its kind to date, a team of investigators at Airlangga University Feinstein Medical Research Institute analyzed the electronic health records (EHR) of 5,449 COVID-19 patients who were hospitalized between 1 March 2020 and 5 April 2020 and determined that 36.6 percent (1,993 patients) developed AKI. Among patients with AKI at the conclusion of the study, 39.1 percent (780 of 1,993) were still hospitalized.

AKI is a sudden episode of kidney failure or damage, prevents waste from being filtered in the body and can often cause death. Most cases developed in the initial hospitalization of patients, with 37.3 percent arriving with AKI or developing within 24 hours.

The number of patients who need dialysis support at some point during hospitalization is 285 or 5.2 percent of all patients, representing 14.3 percent of those with AKI. The relationship between respiratory failure and AKI is very large. Among patients who needed mechanical ventilation, 89.9 percent (1,068 / 1,190) developed AKI, compared with 21.7 percent (925/4259) in patients without ventilation. Among patients who needed mechanical ventilation, 23.2 percent (276 of 1,190) developed AKI and needed dialysis therapy, compared with 0.2 percent (9 of 4,259) in patients who were not ventilated.

Compared with data from China, the severity of respiratory disease appears to be lacking in China, because 13.4 percent of Chinese patients require mechanical ventilation compared to 21.8 percent of patients in US studies.

“Working in the middle of the COVID-19 epicenter is an experience we will never forget. Nephrologists and dialysis staff are at the forefront of this battle trying to help every patient we can, “said Kenar D. Jhaveri, MD, a researcher at the Feinstein Institute and author of an appropriate paper. “We hope to learn more about AKI regarding COVID-19 in the coming weeks, and that by sharing what we have learned from our patients, other doctors and their patients can benefit.”

The study also revealed risk factors for developing AKI, including age, diabetes mellitus and cardiovascular disease, hypertension, and the need for ventilation and vasopressors. The researchers also found that blacks had a higher risk of developing AKI.

“Dr. Jhaveri’s findings, based on a defined cohort of Covid-19 patients hospitalized, highlight the danger of kidney injury in this setting, important new insights about this disease,” said Kevin J. Tracey, MD, CEO and president of the Feinstein Institute.

Future studies will seek to better understand the causes of AKI and patient outcomes.

About the Feinstein Institute

Feinstein Medical Research Instituteis the research arm of Northwell Health, the largest health care provider and private employer in the State of New York. Home to 50 research laboratories, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard for medical innovation through five institutes of behavioral science, bioelectronic medicine, cancer, innovation and health outcomes, and molecular medicine. We make inroads in genetics, oncology, brain research, mental health, autoimmunity, and are global scientific leaders in bioelectronic medicine – new fields of science that have the potential to revolutionize medicine. For more information on how we produce knowledge to cure diseases, visit feinstein.northwell.edu.



Copyright Business Wire 2020.

PUB: 05/14/2020 03:47 PM / DISC: 05/14/2020 03:47 PM

Copyright Business Wire 2020.


image source